Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - fingolimod hcl 0.56 mg eqv fingolimod - capsule - 0.5mg - fingolimod hcl 0.56 mg eqv fingolimod 0.5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - fingolimod hydrochloride - capsule - 500microgram

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - fingolimod hcl 0.28mg eqv fingolimod - capsule - fingolimod hcl 0.28mg eqv fingolimod 0.25mg

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة مستودع الأدوية الأردني - the jordan drugstore co - fingolimod 0.5 mg - 0.5 mg

Malta - English - Medicines Authority

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - hard capsule - fingolimod 0.5 mg - immunosuppressants

Israel - English - Ministry of Health

novartis israel ltd - fingolimod as hydrochloride - hard capsule - fingolimod as hydrochloride 0.5 mg - fingolimod - fingolimod - gilenya is indicated for the treatment of patients with relapsing forms of multiple sclerosis ( ms ) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability.

European Union - English - EMA (European Medicines Agency)

novartis europharm limited - fingolimod hydrochloride  - multiple sclerosis - immunosuppressants - gilenya is indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult patients and paediatric patients aged 10 years and older:patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4.4 and 5.1).orpatients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Canada - English - Health Canada

marcan pharmaceuticals inc - fingolimod (fingolimod hydrochloride) - capsule - 0.5mg - fingolimod (fingolimod hydrochloride) 0.5mg - immunomodulatory agents

Israel - English - Ministry of Health

teva israel ltd - fingolimod as hydrochloride - capsules - fingolimod as hydrochloride 0.5 mg - fingolimod - indicated for the treatment of patients with relapsing forms of multiple sclerosis ( ms ) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disabiliry.

Israel - English - Ministry of Health

novartis israel ltd - fingolimod as hydrochloride - hard capsule - fingolimod as hydrochloride 0.5 mg - fingolimod - fingolimod sandoz is indicated for the treatment of patients with relapsing forms of multiple sclerosis ( ms ) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability.